Trump signs order to reclassify marijuana, ease research restrictions
PositiveWorld Affairs
- Former President Donald Trump has signed an executive order to reclassify marijuana, directing the US attorney general to expedite federal reclassification and reduce barriers for research studies. This marks a significant shift in U.S. drug policy, aligning cannabis with substances like Tylenol with codeine, a change not seen since 1971.
- This development is crucial as it opens the door for increased research into cannabis, potentially leading to new medical applications and a reevaluation of its legal status, which could impact public health and safety policies across the nation.
- The reclassification of marijuana reflects a broader trend in drug policy reform, contrasting with the administration's recent designation of fentanyl as a 'weapon of mass destruction.' This dual approach highlights ongoing debates about drug regulation, public health priorities, and the complexities of addressing substance use in America.
— via World Pulse Now AI Editorial System



